FierceBiotech ٣٠ مارس ٢٠٢٦ Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community
FierceBiotech ٣٠ مارس ٢٠٢٦ Johnson & Johnson’s Impella pumps miss the mark in 2 major coronary studies
FierceBiotech ٣٠ مارس ٢٠٢٦ Viridian’s other rival to Amgen’s Tepezza scores phase 3 win, but investors need convincing
FierceBiotech ٣٠ مارس ٢٠٢٦ Boston Scientific’s Watchman heart implant measures up to blood thinners in ACC trial
FierceBiotech ٣٠ مارس ٢٠٢٦ Merck dives into detailed phase 3 data showing PCSK9 pill easily outswims rivals
FierceBiotech ٣٠ مارس ٢٠٢٦ Kailera plots IPO to fund obesity pipeline after one of the biggest raises of 2025
FierceBiotech ٣٠ مارس ٢٠٢٦ Biogen’s litifilimab sparkles in midphase lupus trial, raising hopes for pivotal readout
FierceBiotech ٣٠ مارس ٢٠٢٦ Kardigan hypertension drug tangles biomarker win with blood pressure miss in phase 2 trial
FierceBiotech ٣٠ مارس ٢٠٢٦ Lilly further embraces Insilico’s AI tech, inking R&D collab worth up to $2.75B
FierceBiotech ٢٧ مارس ٢٠٢٦ 'We need to put some bad ideas to bed': Inside Incubate's battles for biotech on Capitol Hill
FierceBiotech ٢٧ مارس ٢٠٢٦ After local tumor approval, Novocure touts positive data in metastatic pancreatic cancer
FierceBiotech ٢٧ مارس ٢٠٢٦ Otsuka buys Transcend in $1.2B deal, nabbing MDMA analog for psychiatric conditions
FierceBiotech ٢٧ مارس ٢٠٢٦ AstraZeneca’s in vivo CAR-T bet eradicates cancer in 3 of 5 patients, but death mars dataset